Chemoprevention: reducing risk, not treating the disease
Chemoprevention refers to the use of natural or pharmaceutical substances to reduce the risk of developing cancer or to slow its progression. Ginger fits into this category thanks to several well-documented molecular mechanisms.
Cancers for which ginger research is most advanced:
- Colorectal cancer (most studied)
- Stomach cancer
- Breast cancer (mainly in vitro)
- Prostate cancer
- Hepatocellular carcinoma
- Pancreatic cancer
Molecular anti-cancer mechanisms of ginger
1. Inhibition of NF-κB — the central target
NF-κB is the master transcription factor of inflammation AND tumor cell survival. Cancer cells constitutively overexpress NF-κB to avoid apoptosis (programmed death). Gingerols (6-gingerol, 6-paradol) inhibit NF-κB → reduction of anti-apoptotic gene expression (Bcl-2, survivin, XIAP) → tumor cells become sensitive to apoptosis again.
2. Induction of apoptosis
[6]-shogaols induce apoptosis via two pathways:
- Intrinsic pathway (mitochondrial): activation of Bax, release of cytochrome c → activation of caspases 3 and 9
- Extrinsic pathway (death receptors): upregulation of TRAIL-R1/R2 → receptor-dependent cell death
A study by Kim et al. (2008) showed that [6]-gingerol induced apoptosis in MCF-7 cells (breast cancer) with an IC50 of 47 µM — comparable to some natural chemotherapeutic agents.
3. Anti-angiogenesis of tumors
Tumors create their own vascular network via VEGF to nourish themselves (tumor angiogenesis). Gingerols:
- Inhibit the expression of VEGF-A and the receptor VEGFR-2
- Reduce migration and invasion of endothelial cells
- Inhibit the formation of vascular tubes in vitro
4. Ginger and chemotherapy: potentiation and nausea
Ginger has a dual benefit in an oncological context:
- Chemotherapy-induced nausea (CINV): evidence level A — 1–2 g/day ginger reduces chemotherapy-induced nausea and vomiting by 40–45%
- Potentiation of certain agents: some in vitro studies suggest synergy ginger + 5-FU (colorectal), ginger + paclitaxel (breast) — preliminary data not confirmed in clinical setting
FAQ Cancer and ginger
Can ginger cure cancer?
No. No clinical data shows that ginger treats or cures established cancer. Positive studies are mainly in vitro (cells in laboratory) or in vivo (animals), often with doses well above what a human can consume. Ginger is a tool for chemoprevention and support, not a curative treatment.
What doses of ginger for chemoprevention?
Human studies on chemotherapy-induced nausea use 1–2 g/day of standardized extract or the equivalent in fresh ginger. For nutritional chemoprevention, 2–4 g of fresh ginger/day (= 1 INTI shot of 60 ml ≈ 7 g) is a plausible and well-tolerated dose. Above 4 g/day, there is a risk of gastric irritation.
Anti-NF-κB · Natural anti-angiogenic · 7 g fresh organic cold-pressed ginger
Order on inti-drink.com →
Related articles
Further reading on related topics :
- Ginger and cancer: prevention mechanisms, apoptosis, VEGF and the role of dietary sugar
- Ginger & Cancer Prevention: Apoptosis, Angiogenesis Inhibition & Oncological Support
- Ginger and cancer prevention: what science says — and why comparison INTI vs GIMBER-sugar sabotages it
- Sugary drinks, insulin and colorectal cancer: why Belgian men and women choose INTI
- Ginger and digestive cancers: colon, stomach and pancreas — NF-κB tumoral, apoptosis and AMPK/mTORC1 — INTI
- Colorectal cancer in Belgium: sugar, Wnt/β-catenin and ginger (2025)
- Cardiovascular diseases in Belgium: sugar, platelets, TXA2 and ginger (2025)
- Colon cancer in Belgium: sugary drinks, microbiome and prevention — role of ginger